This research project involves the development of an experimental and modeling approach to evaluate the impact (i.e. additional risk) that smoking and alcohol consumption has on agricultural workers who are routinely exposed to insecticides. Drug/chemical interactions share a common theme in which pharmacokinetic and pharmacodynamic responses are altered when chemical mixtures modify absorption rates, metabolism, tissue distribution, clearance and pharmacological action. It is hypothesized that the use of tobacco products and the consumption of alcoholic beverages at pharmacologically active doses (associated with normal use patterns) can influence key metabolic and dynamic processes modifying dosimetry and biological response following both acute and repeat exposures to insecticides. Among pesticides, organophosphorus insecticides like chlorpyrifos have been of particular concern since they are widely utilized, are neurotoxic, and a number of studies have documented both occupational and non-occupational exposures in adults and children. The mode of action for organophosphorus insecticides involves their capacity to inhibit acetylcholinesterase (AChE) activity resulting in the accumulation of acetylcholine within the cholinergic synapse thereby producing a wide range of neurotoxic responses. Previously, research on this project resulted in the development and validation of physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) models for insecticides (chlorpyrifos and diazinon). These models were shown to accurately simulate dosimetry and ChE inhibition in both rats and humans. This continuation project will focus on extending that research to evaluate the impact of prior exposure to tobacco/nicotine and ethanol. The rationale for this approach is based on the known high exposures associated with routine use of tobacco and ethanol and the capability of nicotine and ethanol to modify metabolism potentially impacting insecticide dosimetry. Additionally, nicotine and ethanol are known to impact cholinergic receptor (nicotinic and muscarinic) function which is also a key pharmacodynamic target for organophosphorus insecticides. The project will assess biological and metabolic changes, target tissue dosimetry, and dynamic responses to these pesticides following co-exposures with tobacco/nicotine and ethanol. The results will be integrated into a computational framework to quantitatively assess the health implications from insecticide exposures. The development of experimental in vitro data in human cells represents an important surrogate human experimental model system and the results will likewise be integrated into the modeling framework to help predict health effects in humans. It is fully anticipated that this approach will facilitate the understanding of a variety of complex chemical interactions as it relates to the occupational health implications of working with insecticides. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute for Occupational Safety and Health (NIOSH)
Type
Research Project (R01)
Project #
5R01OH003629-05
Application #
7406063
Study Section
Safety and Occupational Health Study Section (SOH)
Program Officer
Board, Susan
Project Start
2001-09-30
Project End
2010-03-31
Budget Start
2008-04-01
Budget End
2009-03-31
Support Year
5
Fiscal Year
2008
Total Cost
$426,814
Indirect Cost
Name
Battelle Pacific Northwest Laboratories
Department
Type
DUNS #
032987476
City
Richland
State
WA
Country
United States
Zip Code
99352
Smith, Jordan Ned; Wang, Jun; Lin, Yuehe et al. (2012) Pharmacokinetics and Pharmacodynamics of chlorpyrifos and 3,5,6-trichloro-2-pyridinol in rat saliva after chlorpyrifos administration. Toxicol Sci 130:245-56
Lee, S; Poet, T S; Smith, J N et al. (2011) Impact of repeated nicotine and alcohol coexposure on in vitro and in vivo chlorpyrifos dosimetry and cholinesterase inhibition. J Toxicol Environ Health A 74:1334-50
Smith, Jordan N; Wang, Jun; Lin, Yuehe et al. (2010) Pharmacokinetics of the chlorpyrifos metabolite 3,5,6-trichloro-2-pyridinol (TCPy) in rat saliva. Toxicol Sci 113:315-25
Lee, Sookwang; Poet, Torka S; Smith, Jordan N et al. (2010) Effect of in vivo nicotine exposure on chlorpyrifos pharmacokinetics and pharmacodynamics in rats. Chem Biol Interact 184:449-57
Busby-Hjerpe, Andrea L; Campbell, James A; Smith, Jordan Ned et al. (2010) Comparative pharmacokinetics of chlorpyrifos versus its major metabolites following oral administration in the rat. Toxicology 268:55-63
Lee, S; Busby, A L; Timchalk, C et al. (2009) Effects of nicotine exposure on in vitro metabolism of chlorpyrifos in male Sprague-Dawley rats. J Toxicol Environ Health A 72:74-82
Smith, Jordan Ned; Campbell, James A; Busby-Hjerpe, Andrea L et al. (2009) Comparative chlorpyrifos pharmacokinetics via multiple routes of exposure and vehicles of administration in the adult rat. Toxicology 261:47-58
Garabrant, David H; Aylward, Lesa L; Berent, Stanley et al. (2009) Cholinesterase inhibition in chlorpyrifos workers: Characterization of biomarkers of exposure and response in relation to urinary TCPy. J Expo Sci Environ Epidemiol 19:634-42
Timchalk, C; Poet, T S (2008) Development of a physiologically based pharmacokinetic and pharmacodynamic model to determine dosimetry and cholinesterase inhibition for a binary mixture of chlorpyrifos and diazinon in the rat. Neurotoxicology 29:428-43
Cole, Toby B; Walter, Betsy J; Shih, Diana M et al. (2005) Toxicity of chlorpyrifos and chlorpyrifos oxon in a transgenic mouse model of the human paraoxonase (PON1) Q192R polymorphism. Pharmacogenet Genomics 15:589-98

Showing the most recent 10 out of 11 publications